Enzymatica AB Statistics
Total Valuation
Enzymatica AB has a market cap or net worth of SEK 475.76 million. The enterprise value is 443.65 million.
| Market Cap | 475.76M |
| Enterprise Value | 443.65M |
Important Dates
The last earnings date was Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enzymatica AB has 242.74 million shares outstanding. The number of shares has increased by 25.94% in one year.
| Current Share Class | 242.74M |
| Shares Outstanding | 242.74M |
| Shares Change (YoY) | +25.94% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.01% |
| Owned by Institutions (%) | 14.39% |
| Float | 106.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.83 |
| PB Ratio | 3.83 |
| P/TBV Ratio | 7.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.55 |
| EV / Sales | 8.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.77 |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.65 |
| Quick Ratio | 2.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -41.73 |
Financial Efficiency
Return on equity (ROE) is -34.53% and return on invested capital (ROIC) is -21.14%.
| Return on Equity (ROE) | -34.53% |
| Return on Assets (ROA) | -19.04% |
| Return on Invested Capital (ROIC) | -21.14% |
| Return on Capital Employed (ROCE) | -41.37% |
| Weighted Average Cost of Capital (WACC) | 6.38% |
| Revenue Per Employee | 2.70M |
| Profits Per Employee | -2.59M |
| Employee Count | 20 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.17 |
Taxes
In the past 12 months, Enzymatica AB has paid 51,000 in taxes.
| Income Tax | 51,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.80% in the last 52 weeks. The beta is 0.35, so Enzymatica AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +1.80% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 2.31 |
| Relative Strength Index (RSI) | 54.59 |
| Average Volume (20 Days) | 91,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Enzymatica AB had revenue of SEK 53.90 million and -51.89 million in losses. Loss per share was -0.21.
| Revenue | 53.90M |
| Gross Profit | 33.13M |
| Operating Income | -51.37M |
| Pretax Income | -51.84M |
| Net Income | -51.89M |
| EBITDA | -48.54M |
| EBIT | -51.37M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 33.13 million in cash and 1.02 million in debt, with a net cash position of 32.11 million or 0.13 per share.
| Cash & Cash Equivalents | 33.13M |
| Total Debt | 1.02M |
| Net Cash | 32.11M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 124.17M |
| Book Value Per Share | 0.51 |
| Working Capital | 47.23M |
Cash Flow
In the last 12 months, operating cash flow was -40.97 million and capital expenditures -231,000, giving a free cash flow of -41.20 million.
| Operating Cash Flow | -40.97M |
| Capital Expenditures | -231,000 |
| Free Cash Flow | -41.20M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 61.45%, with operating and profit margins of -95.30% and -96.27%.
| Gross Margin | 61.45% |
| Operating Margin | -95.30% |
| Pretax Margin | -96.17% |
| Profit Margin | -96.27% |
| EBITDA Margin | -90.05% |
| EBIT Margin | -95.30% |
| FCF Margin | n/a |
Dividends & Yields
Enzymatica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.94% |
| Shareholder Yield | -25.94% |
| Earnings Yield | -10.91% |
| FCF Yield | -8.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |